AGN-229666 for the Treatment of Allergic Conjunctivitis

This study will evaluate the safety and efficacy of AGN-229666 for the treatment of allergic conjunctivitis.

Inclusion Criteria:

• Japanese patients living in Japan with a history of allergic conjunctivitis
• Willing to discontinue wearing contact lenses during the study period

Exclusion Criteria:

• Use of nicotine products during the study period
• Presence of active eye infection (bacterial, viral, or fungal)
• History of an ocular herpetic infection
• Eye surgery intervention within 3 months and/or a history of refractive surgery within the past 6 months